LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Public ClinicalTrials.gov record NCT03412890. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
LIBERTY EXTENSION: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to determine the long-term efficacy and safety of relugolix 40 milligrams (mg) once daily co-administered with estradiol (E2) and norethindrone acetate (NETA) for 28 weeks on heavy menstrual bleeding associated with uterine fibroids in participants who previously completed a 24-week treatment period in one of the pivotal studies (MVT-601-3001 or MVT-601-3002).
Study identification
- NCT ID
- NCT03412890
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 477 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 19, 2017 (Actual)
- Primary completion
- Jan 21, 2020 (Actual)
- Completion
- Jan 13, 2021 (Actual)
- Last update posted
- May 9, 2024
2017 – 2021
United States locations
- U.S. sites
- 104
- U.S. states
- 27
- U.S. cities
- 87
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Andalusia | Andalusia | Alabama | 36420 | — |
| Birmingham | Birmingham | Alabama | 35205 | — |
| Mobile | Mobile | Alabama | 36608 | — |
| Mesa | Mesa | Arizona | 85209 | — |
| Tucson | Tucson | Arizona | 85712 | — |
| Little Rock | Little Rock | Arkansas | 72204 | — |
| Canoga Park | Canoga Park | California | 91303 | — |
| Huntington Beach | Huntington Beach | California | 92647 | — |
| La Mesa | La Mesa | California | 91942 | — |
| Long Beach | Long Beach | California | 90806 | — |
| Los Angeles | Los Angeles | California | 90036 | — |
| Los Angeles | Los Angeles | California | 90057 | — |
| Norwalk | Norwalk | California | 90650 | — |
| Panorama | Panorama City | California | 91402 | — |
| San Diego | San Diego | California | 92108 | — |
| San Diego | San Diego | California | 92111 | — |
| Denver | Denver | Colorado | 80209 | — |
| Lakewood | Lakewood | Colorado | 80228 | — |
| Washington | Washington D.C. | District of Columbia | 20036 | — |
| Aventura | Aventura | Florida | 33180 | — |
| Clearwater | Clearwater | Florida | 33759 | — |
| DeLand | DeLand | Florida | 32720 | — |
| Ft. Lauderdale | Fort Lauderdale | Florida | 33316 | — |
| Fort Myers | Fort Myers | Florida | 33912 | — |
| Hialeah | Hialeah | Florida | 33016 | — |
| Jacksonville | Jacksonville | Florida | 32207 | — |
| Jupiter | Jupiter | Florida | 33458 | — |
| Loxahatchee | Loxahatchee Groves | Florida | 33470 | — |
| Margate | Margate | Florida | 33063 | — |
| Miami | Miami | Florida | 33126 | — |
| Miami | Miami | Florida | 33155 | — |
| Miami | Miami | Florida | 33165 | — |
| New Port Richey | New Port Richey | Florida | 34652 | — |
| Orlando | Orlando | Florida | 32808 | — |
| Oviedo | Oviedo | Florida | 32765 | — |
| Palm Harbor | Palm Harbor | Florida | 34684 | — |
| Saint Cloud | Saint Cloud | Florida | 34769 | — |
| Sarasota | Sarasota | Florida | 34239 | — |
| Tampa | Tampa | Florida | 33606 | — |
| Tampa | Tampa | Florida | 33613 | — |
| West Palm Beach | West Palm Beach | Florida | 33409 | — |
| Weston | Weston | Florida | 33327 | — |
| Atlanta | Atlanta | Georgia | 30342 | — |
| Atlanta | Atlanta | Georgia | 30363 | — |
| Augusta | Augusta | Georgia | 30904 | — |
| College Park | College Park | Georgia | 30349 | — |
| Decatur | Decatur | Georgia | 30034 | — |
| Duluth | Duluth | Georgia | 30097 | — |
| Norcross | Norcross | Georgia | 30093 | — |
| Savannah | Savannah | Georgia | 31406 | — |
| Chicago | Chicago | Illinois | 60611 | — |
| Naperville | Naperville | Illinois | 60540 | — |
| Oakbrook | Oakbrook Terrace | Illinois | 60523 | — |
| Shawnee | Shawnee Mission | Kansas | 66218 | — |
| Covington | Covington | Louisiana | 70433 | — |
| Marrero | Marrero | Louisiana | 70072 | — |
| Metairie | Metairie | Louisiana | 70001 | — |
| Metairie | Metairie | Louisiana | 70006 | — |
| Baltimore | Baltimore | Maryland | 21208 | — |
| Towson | Towson | Maryland | 21204 | — |
| Canton | Canton | Michigan | 48187 | — |
| Detroit | Detroit | Michigan | 48201 | — |
| Saginaw | Saginaw | Michigan | 48604 | — |
| Lincoln | Lincoln | Nebraska | 68510 | — |
| Las Vegas | Las Vegas | Nevada | 89109 | — |
| Las Vegas | Las Vegas | Nevada | 89113 | — |
| Las Vegas | Las Vegas | Nevada | 89128 | — |
| Lawrenceville | Lawrenceville | New Jersey | 08648 | — |
| Albuquerque | Albuquerque | New Mexico | 87102 | — |
| Brooklyn | Brooklyn | New York | 11201 | — |
| New York | New York | New York | 10022 | — |
| Williamsville | Williamsville | New York | 14221 | — |
| Durham | Durham | North Carolina | 27713 | — |
| Raleigh | Raleigh | North Carolina | 27607 | — |
| Raleigh | Raleigh | North Carolina | 27612 | — |
| Winston-Salem | Winston-Salem | North Carolina | 27103 | — |
| Cincinnati | Cincinnati | Ohio | 45212 | — |
| Cincinnati | Cincinnati | Ohio | 45219 | — |
| Columbus | Columbus | Ohio | 43231 | — |
| Englewood | Englewood | Ohio | 45322 | — |
| Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Bluffton | Bluffton | South Carolina | 29910 | — |
| Charleston | Charleston | South Carolina | 29406 | — |
| Columbia | Columbia | South Carolina | 29201 | — |
| Chattanooga | Chattanooga | Tennessee | 37404 | — |
| Memphis | Memphis | Tennessee | 38119 | — |
| Memphis | Memphis | Tennessee | 38120 | — |
| Beaumont | Beaumont | Texas | 77702 | — |
| Dallas | Dallas | Texas | 75231 | — |
| Fort Worth | Fort Worth | Texas | 76104 | — |
| Houston | Houston | Texas | 77030 | — |
| Houston | Houston | Texas | 77054 | — |
| Houston | Houston | Texas | 77074 | — |
| Longview | Longview | Texas | 75605 | — |
| San Antonio | San Antonio | Texas | 78229 | — |
| San Antonio | San Antonio | Texas | 78258 | — |
| Sugar Land | Sugar Land | Texas | 77479 | — |
| Webster | Webster | Texas | 77598 | — |
| Salt Lake City | Salt Lake City | Utah | 84107 | — |
| Salt Lake City | Salt Lake City | Utah | 84124 | — |
| Norfolk | Norfolk | Virginia | 23502 | — |
| Norfolk | Norfolk | Virginia | 23507 | — |
| Richmond | Richmond | Virginia | 23225 | — |
| Spokane | Spokane | Washington | 99207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03412890, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03412890 live on ClinicalTrials.gov.